Latest price targets
| Date | Symbol | News | Price Target | Price When Posted |
|---|---|---|---|---|
| 2024-09-06 10:07 AM | Salesforce deal leaves 'ample' cash for buybacks, says Jefferies Brent Thill | Jefferies |
$350.00 | $242.66 | |
| 2024-09-06 09:54 AM | Broadcom Analysts Highlight Long-Term Potential: 'High-Quality AI Franchise' Could Provide Upside In 2025 John Vinh | KeyBanc |
$210.00 | $137.00 | |
| 2024-09-06 09:29 AM | MicroStrategy Poised for Growth With Strong Bitcoin Exposure and Software Expansion: Analyst Ramsey El-Assal | Barclays |
$146.00 | $0.00 | |
| 2024-09-06 08:03 AM | Rent The Runway price target lowered to $26 from $34 at Jefferies Ashley Helgans | Jefferies |
$26.00 | $11.89 | |
| 2024-09-06 07:07 AM | UiPath Q2 Results Reflect Restructuring Benefits, Analysts Praise 'Laser-Focus' On AI Matthew Hedberg | RBC Capital |
$16.00 | $12.06 | |
| 2024-09-06 05:37 AM | Samsara price target raised to $49 from $47 at RBC Capital Matthew Hedberg | RBC Capital |
$49.00 | $44.34 | |
| 2024-09-06 05:28 AM | Uber's quarter tracking in-line for Mobility, ahead for Delivery, says Truist Youssef Squali | Truist Financial |
$88.00 | $71.08 | |
| 2024-09-06 05:06 AM | These Analysts Boost Their Forecasts On Guidewire Software Following Upbeat Q4 Results Ken Wong | Oppenheimer |
$185.00 | $162.96 | |
| 2024-09-06 05:06 AM | These Analysts Boost Their Forecasts On Guidewire Software Following Upbeat Q4 Results Rishi Jaluria | RBC Capital |
$180.00 | $162.96 | |
| 2024-09-06 04:44 AM | Phreesia price target raised to $31 from $29 at Truist Jailendra Singh | Truist Financial |
$31.00 | $25.69 | |
| 2024-09-06 04:33 AM | Costco price target raised to $975 from $970 at Loop Capital Laura Champine | Loop Capital Markets |
$975.00 | $885.98 | |
| 2024-09-06 04:21 AM | Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 3% Dividend Yields Ross Muken | Evercore ISI |
$28.00 | $21.17 | |
| 2024-09-06 04:16 AM | Smartsheet price target raised to $57 from $55 at Morgan Stanley Josh Baer | Morgan Stanley |
$57.00 | $49.35 | |
| 2024-09-06 03:48 AM | Costco price target raised to $955 from $925 at Oppenheimer Rupesh Parikh | Oppenheimer |
$955.00 | $885.98 | |
| 2024-09-06 03:42 AM | Samsara Inc (IOT) PT Raised to $44 at BMO Capital Daniel Jester | BMO Capital |
$44.00 | $38.75 | |
| 2024-09-06 03:39 AM | DTE Energy (DTE) PT Raised to $135 at BMO Capital James Thalacker | BMO Capital |
$135.00 | $123.66 | |
| 2024-09-06 03:38 AM | Domino's Pizza (DPZ) PT Lowered to $490 at Oppenheimer Brian Bittner | Oppenheimer |
$490.00 | $410.26 | |
| 2024-09-06 03:38 AM | Live Nation Entertainment (LYV) PT Raised to $120 at Oppenheimer Jed Kelly | Oppenheimer |
$120.00 | $94.20 | |
| 2024-09-06 03:37 AM | Piper Sandler Reiterates Neutral Rating on Docusign Inc. (DOCU) Rob Owens | Piper Sandler |
$60.00 | $56.93 | |
| 2024-09-06 03:36 AM | Samsara Inc (IOT) PT Raised to $40 at Piper Sandler James Fish | Piper Sandler |
$40.00 | $38.75 | |
| 2024-09-06 03:34 AM | Piper Sandler Reiterates Overweight Rating on Braze Inc (BRZE) Brent Bracelin | Piper Sandler |
$51.00 | $44.13 | |
| 2024-09-06 03:26 AM | Smartsheet price target raised to $59 from $48 at BMO Capital Keith Bachman | BMO Capital |
$59.00 | $49.35 | |
| 2024-09-06 03:26 AM | Piper Sandler Reiterates Overweight Rating on OrthoPediatrics Corp. (KIDS) Matt O'Brien | Piper Sandler |
$44.00 | $29.88 | |
| 2024-09-06 03:22 AM | Citi Reiterates Buy Rating on CoStar Group (CSGP) Peter Christiansen | Citigroup |
$97.00 | $77.36 | |
| 2024-09-06 03:21 AM | Citi Reiterates Neutral Rating on Peloton Interactive (PTON) Ronald Josey | Citigroup |
$4.75 | $4.77 | |
| 2024-09-06 03:13 AM | Life Time Group price target raised to $30 from $29 at BofA Alexander Perry | Bank of America Securities |
$30.00 | $23.88 | |
| 2024-09-06 03:12 AM | Baird Reiterates Outperform Rating on PayPal (PYPL) Colin Sebastian | Robert W. Baird |
$80.00 | $72.03 | |
| 2024-09-06 03:11 AM | Baird Reiterates Outperform Rating on Lululemon Athletica Inc. (LULU) Mark Altschwager | Robert W. Baird |
$350.00 | $253.70 | |
| 2024-09-06 03:10 AM | Baird Reiterates Outperform Rating on Longboard Pharmaceuticals Inc (LBPH) Joel Beatty | Robert W. Baird |
$60.00 | $33.89 | |
| 2024-09-06 03:09 AM | Baird Reiterates Outperform Rating on Costco Wholesale (COST) Peter Benedict | Robert W. Baird |
$975.00 | $885.98 | |
| 2024-09-06 03:06 AM | Guidewire (GWRE) PT Raised to $175 at Stifel Parker Lane | Stifel Nicolaus |
$175.00 | $143.93 | |
| 2024-09-06 03:05 AM | Adobe (ADBE) PT Raised to $650 at Stifel Parker Lane | Stifel Nicolaus |
$650.00 | $567.93 | |
| 2024-09-06 03:03 AM | Smartsheet Inc. (SMAR) PT Raised to $60 at Truist Securities Terry Tillman | Truist Financial |
$60.00 | $49.35 | |
| 2024-09-06 03:03 AM | Shoals Technologies Group (SHLS) PT Lowered to $8 at Truist Securities Jordan Levy | Truist Financial |
$8.00 | $5.48 | |
| 2024-09-06 03:03 AM | Science Applications (SAIC) PT Raised to $135 at Truist Securities Tobey Sommer | Truist Financial |
$135.00 | $135.28 | |
| 2024-09-06 03:02 AM | Broadcom Limited (AVGO) PT Lowered to $204 at Truist Securities William Stein | Truist Financial |
$204.00 | $152.82 | |
| 2024-09-06 03:00 AM | Rosenblatt Reiterates Buy Rating on Broadcom Limited (AVGO) Hans Mosesmann | Rosenblatt Securities |
$240.00 | $152.82 | |
| 2024-09-06 03:00 AM | Citi opens 'positive catalyst watch' on Corning into investor event Asiya Merchant | Citigroup |
$50.00 | $41.37 | |
| 2024-09-06 02:59 AM | Barclays Upgrades RadNet (RDNT) to Overweight Andrew Mok | Barclays |
$79.00 | $63.19 | |
| 2024-09-06 02:57 AM | CrowdStrike Holdings (CRWD) PT Lowered to $310 at Susquehanna Shyam Patil | Susquehanna |
$310.00 | $256.43 | |
| 2024-09-06 02:54 AM | H.C. Wainwright Reiterates Buy Rating on Kalvista Pharmaceuticals Inc (KALV) Andrew Fein | H.C. Wainwright |
$20.00 | $12.87 | |
| 2024-09-06 02:53 AM | H.C. Wainwright Reiterates Buy Rating on Aurinia Pharmaceuticals (AUPH) Ed Arce | H.C. Wainwright |
$13.00 | $6.91 | |
| 2024-09-06 02:49 AM | Canaccord Genuity Reiterates Buy Rating on SharkNinja (SN) Brian McNamara | Canaccord Genuity |
$105.00 | $97.34 | |
| 2024-09-06 02:49 AM | Methode Electronics price target lowered to $13 from $15 at Baird Luke Junk | Robert W. Baird |
$13.00 | $10.34 | |
| 2024-09-06 02:48 AM | Canaccord Genuity Reiterates Buy Rating on Bowlero Corp. (BOWL) Jason Tichen | Canaccord Genuity |
$18.00 | $10.79 | |
| 2024-09-06 02:47 AM | Costco price target raised to $915 from $910 at Stifel Mark Astrachan | Stifel Nicolaus |
$915.00 | $885.98 | |
| 2024-09-06 02:46 AM | Traeger Inc. (COOK) PT Raised to $6 at Canaccord Genuity Brian McNamara | Canaccord Genuity |
$6.00 | $3.47 | |
| 2024-09-06 02:42 AM | Toro (TTC) PT Lowered to $92 at Baird Timothy Wojs | Robert W. Baird |
$92.00 | $81.82 | |
| 2024-09-06 02:42 AM | Phreesia Inc. (PHR) PT Raised to $34 at Baird Joe Vruwink | Robert W. Baird |
$34.00 | $25.69 | |
| 2024-09-06 02:41 AM | Cencora Inc (COR) PT Lowered to $283 at Baird David Rodgers | Robert W. Baird |
$283.00 | $236.24 | |
| 2024-09-06 02:41 AM | Guidewire (GWRE) PT Raised to $175 at Baird Jon Vruwink | Robert W. Baird |
$175.00 | $143.93 | |
| 2024-09-06 02:41 AM | Docusign Inc. (DOCU) PT Raised to $59 at Baird William Power | Robert W. Baird |
$59.00 | $56.93 | |
| 2024-09-06 02:37 AM | BTIG Reiterates Buy Rating on OrthoPediatrics Corp. (KIDS) Ryan Zimmerman | BTIG |
$44.00 | $29.88 | |
| 2024-09-06 02:37 AM | Needham Reiterates Buy Rating on salesforce.com (CRM) Scott Berg | Needham |
$345.00 | $246.12 | |
| 2024-09-06 02:36 AM | McKesson (MCK) PT Lowered to $665 at Leerink Partners Michael Cherny | Leerink Partners |
$665.00 | $514.75 | |
| 2024-09-06 02:35 AM | Leerink Partners Reiterates Outperform Rating on Kalvista Pharmaceuticals Inc (KALV) Joseph Schwartz | Leerink Partners |
$20.00 | $12.87 | |
| 2024-09-06 02:34 AM | B.Riley Reiterates Buy Rating on Performant Financial (PFMT) Kyle Bauser | B.Riley Financial |
$8.00 | $3.60 | |
| 2024-09-06 02:34 AM | Mizuho Reiterates Outperform Rating on Broadcom Limited (AVGO) Vijay Rakesh | Mizuho Securities |
$190.00 | $152.82 | |
| 2024-09-06 02:33 AM | B.Riley Reiterates Buy Rating on Bowlero Corp. (BOWL) Eric Wold | B.Riley Financial |
$17.00 | $10.79 | |
| 2024-09-06 02:33 AM | Mizuho Reiterates Neutral Rating on Duke Energy (DUK) Anthony Crowdell | Mizuho Securities |
$116.00 | $116.85 | |
| 2024-09-06 02:32 AM | Dollar Tree price target lowered to $120 from $150 at Guggenheim John Heinbockel | Guggenheim |
$120.00 | $68.47 | |
| 2024-09-06 02:31 AM | Morgan Stanley Starts Ingersoll-Rand (IR) at Equalweight Chris Snyder | Morgan Stanley |
$97.00 | $87.61 | |
| 2024-09-06 02:31 AM | Morgan Stanley Starts Johnson Controls (JCI) at Overweight, 'we see sustained HSD Service' Chris Snyder | Morgan Stanley |
$85.00 | $69.38 | |
| 2024-09-06 02:31 AM | Morgan Stanley Starts Rockwell Automation (ROK) at Overweight, 'Ready to ROK' Chris Snyder | Morgan Stanley |
$320.00 | $256.92 | |
| 2024-09-06 02:31 AM | Morgan Stanley Starts Eaton Corporation (ETN) at Overweight, 'Not Your Grandpa's Eaton' Chris Snyder | Morgan Stanley |
$370.00 | $285.72 | |
| 2024-09-06 02:31 AM | Morgan Stanley Starts Trane Technologies (TT) at Overweight, Top Pick Chris Snyder | Morgan Stanley |
$425.00 | $342.91 | |
| 2024-09-06 02:30 AM | Morgan Stanley Starts Hubbell (HUBB) at Equalweight Chris Snyder | Morgan Stanley |
$407.00 | $370.42 | |
| 2024-09-06 02:30 AM | Morgan Stanley Starts Gates Industrial Corp. (GTES) at Equalweight Chris Snyder | Morgan Stanley |
$19.00 | $16.67 | |
| 2024-09-06 02:30 AM | BMO Capital Reiterates Outperform Rating on Integral Ad Science Holding Corp (IAS) Brian Pitz | BMO Capital |
$16.00 | $11.48 | |
| 2024-09-06 02:30 AM | Morgan Stanley Starts Otis Worldwide Corp (OTIS) at Equalweight Chris Snyder | Morgan Stanley |
$97.00 | $92.43 | |
| 2024-09-06 02:30 AM | Morgan Stanley Starts Honeywell International (HON) at Equalweight Chris Snyder | Morgan Stanley |
$210.00 | $202.98 | |
| 2024-09-06 02:30 AM | Morgan Stanley Starts Stanley Black & Decker (SWK) at Equalweight Chris Snyder | Morgan Stanley |
$107.00 | $98.36 | |
| 2024-09-06 02:21 AM | Planet Labs (PL) PT Lowered to $5 at Needham Ryan Koontz | Needham |
$5.00 | $2.48 | |
| 2024-09-06 02:21 AM | Waystar Holding (WAY) PT Raised to $31 at RBC Capital Sean Dodge | RBC Capital |
$31.00 | $26.87 | |
| 2024-09-06 02:20 AM | Smartsheet Inc. (SMAR) PT Raised to $51 at RBC Capital Rishi Jaluria | RBC Capital |
$51.00 | $49.35 | |
| 2024-09-06 02:16 AM | Verizon price target lowered to $44 from $46 at KeyBanc Brandon Nispel | KeyBanc |
$44.00 | $41.31 | |
| 2024-09-06 02:14 AM | Grainger initiated with an Equal Weight at Morgan Stanley Christopher Snyder | Morgan Stanley |
$990.00 | $938.48 | |
| 2024-09-06 02:13 AM | Emerson Electric initiated with an Underweight at Morgan Stanley Christopher Snyder | Morgan Stanley |
$105.00 | $99.97 | |
| 2024-09-06 02:13 AM | Carrier Global initiated with an Equal Weight at Morgan Stanley Christopher Snyder | Morgan Stanley |
$75.00 | $69.04 | |
| 2024-09-06 02:12 AM | Fastenal initiated with an Equal Weight at Morgan Stanley Christopher Snyder | Morgan Stanley |
$72.00 | $65.18 | |
| 2024-09-06 02:11 AM | 3M initiated with an Underweight at Morgan Stanley Christopher Snyder | Morgan Stanley |
$125.00 | $131.40 | |
| 2024-09-06 02:10 AM | Fortive initiated with an Overweight at Morgan Stanley Christopher Snyd | Morgan Stanley |
$89.00 | $72.80 | |
| 2024-09-06 02:04 AM | Draganfly price target adjusted to $7 at H.C. Wainwright Scott Buck | H.C. Wainwright |
$7.00 | $2.31 | |
| 2024-09-06 01:45 AM | DocuSign price target raised to $87 from $86 at Citi Tyler Radke | Citigroup |
$87.00 | $56.93 | |
| 2024-09-06 01:38 AM | Broadcom price target raised to $190 from $185 at Goldman Sachs Toshiya Hari | Goldman Sachs |
$190.00 | $152.82 | |
| 2024-09-06 01:21 AM | Frontier upgraded to Equal Weight from Underweight at Wells Fargo Caleb Stein | Wells Fargo |
$38.50 | $35.00 | |
| 2024-09-06 12:54 AM | Smartsheet price target raised to $50 from $45 at Barclays Ryan MacWilliams | Barclays |
$50.00 | $49.35 | |
| 2024-09-06 12:46 AM | MicroStrategy initiated with an Overweight at Barclays Ramsey El-Assal | Barclays |
$146.00 | $119.57 | |
| 2024-09-06 12:35 AM | Dakota Gold initiated with an Outperform at BMO Capital Andrew Mikitchook | BMO Capital |
$6.00 | $2.32 | |
| 2024-09-06 12:11 AM | Mizuho Upgrades Fortive (FTV) to Outperform Brett Linzey | Mizuho Securities |
$90.00 | $72.80 | |
| 2024-09-05 11:58 PM | Barclays Upgrades Coinbase Global Inc. (COIN) to Equalweight Benjamin Budish | Barclays |
$169.00 | $159.70 | |
| 2024-09-05 09:48 PM | Broadcom Limited (AVGO) PT Raised to $180 at Morgan Stanley Joseph Moore | Morgan Stanley |
$180.00 | $152.82 | |
| 2024-09-05 02:57 PM | OMA upgraded to Overweight from Equal Weight at Morgan Stanley Jens Spiess | Morgan Stanley |
$77.00 | $63.97 | |
| 2024-09-05 02:27 PM | Intra-Cellular upgraded to Overweight from Neutral at Piper Sandler David Amsellem | Piper Sandler |
$92.00 | $72.42 | |
| 2024-09-05 12:29 PM | Burford Capital initiated with a Buy at Deutsche Bank Mark DeVries | Deutsche Bank |
$18.00 | $12.98 | |
| 2024-09-05 12:17 PM | Nurix Therapeutics transferred with an Outperform at Baird Brian Skorney | Robert W. Baird |
$26.00 | $24.44 | |
| 2024-09-05 12:16 PM | Deutsche Bank Upgrades Hubbell (HUBB) to Buy Nicole DeBlase | Deutsche Bank |
$441.00 | $370.42 | |
| 2024-09-05 12:13 PM | Oric Pharmaceuticals initiated with a Buy at Stifel Bradley Canino | Stifel Nicolaus |
$20.00 | $9.48 | |
| 2024-09-05 12:11 PM | Barclays on Tesla (TSLA): 'Germany proposes company car EV subsidies through 2028, likely tailwind to Tesla but more beneficial to German OEMs' Dan Levy | Barclays |
$220.00 | $230.17 | |
| 2024-09-05 12:09 PM | Jefferies Starts Chord Energy Corp (CHRD) at Hold Lloud Byrne | Jefferies |
$160.00 | $137.39 |
Most Active Stock Companies
Latest Articles
Analysts Predict Sky-High Future: Rocket Lab (RKLB) Gets $10 Target
Dec. 22, 2023, 7:36 p.m.
Read ArticleSphere 3D Corp. (Nasdaq: ANY) Surges 468% in a Month: What's Behind the Meteoric Rise?
Dec. 22, 2023, 7:14 p.m.
Read ArticleCompugen Ltd. (Nasdaq: CGEN) Soars 163% Pre-Market on Landmark Immunotherapy Deal with Gilead
Dec. 19, 2023, 12:44 p.m.
Read ArticleTop Market Performers: Unveiling the Success Stories of MLGO, ALT, and RIVN Today!
Dec. 6, 2023, 5:28 p.m.
Read ArticleIlluminating the Path Ahead: Sunrun Inc. (Nasdaq: RUN) Receives Strong Buy Recommendations
Sept. 27, 2023, 6:09 p.m.
Read ArticleWorkday, Inc. (Nasdaq: WDAY) Enhances Workplace Productivity with New Generative AI Capabilities
Sept. 27, 2023, 5:39 p.m.
Read ArticleReata Pharmaceuticals, Inc. (Nasdaq: RETA) Achieves New 52-Week High, Soars Over 689%
Sept. 25, 2023, 4:35 p.m.
Read ArticleRegeneron Pharmaceuticals, Inc. (Nasdaq: REGN) Advances with Decibel Therapeutics Acquisition
Sept. 25, 2023, 12:50 p.m.
Read ArticleCrowdStrike Holdings, Inc. (Nasdaq: CRWD): Analyst Sets Bullish $200.00 Price Target
Sept. 21, 2023, 7:46 p.m.
Read ArticleAnalyst Matt Bryson Sets $80.00 Price Target for Micron Technology, Inc. (Nasdaq: MU)
Sept. 21, 2023, 7:25 p.m.
Read ArticleWhat's Behind Greenland Technologies Holding Corporation (Nasdaq: GTEC) Surge?
Sept. 20, 2023, 8:36 p.m.
Read ArticleMSP Recovery, Inc. (Nasdaq: LIFW) - LifeWallet's Surge: What's Behind the Recent Momentum
Sept. 20, 2023, 2:48 p.m.
Read ArticleT2 Biosystems, Inc. (NASDAQ: TTOO) Hails CDC's Commitment to Battle Sepsis in U.S. Hospitals
Sept. 19, 2023, 12:41 p.m.
Read ArticleDatasea Inc. (NASDAQ: DTSS) Empowers Its Future with $2 Million Public Offering Success
Sept. 19, 2023, 12:29 p.m.
Read ArticleABVC BioPharma, Inc. Progress in ADHD Phase IIb Clinical Study
Sept. 19, 2023, 12:18 p.m.
Read ArticleTerran Orbital Corporation Soars to New Heights with 10 Satellite Deployment
Sept. 19, 2023, noon
Read ArticleFDA Greenlights Orchestra BioMed Holdings Innovative Hypertension Treatment
Sept. 19, 2023, 11:46 a.m.
Read ArticleLatest News
2024-09-08 11:07:00
NEW YORK, NY / ACCESSWIRE / September 8, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of MaxLinear, Inc. ("MaxLinear") (NASDAQ:MXL) concerning possible violations of federal securities laws. On July 24, 2024, after the market closed, MaxLinear announced earnings results for its second quarter of 2024 and that net revenue for the quarter was just $92 million, down 50% year-over-year.
Dyne Therapeutics, Inc. Investigation Ongoing: Contact Levi & Korsinsky to Discuss Your Rights - DYN
2024-09-08 11:07:00
NEW YORK, NY / ACCESSWIRE / September 8, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Dyne Therapeutics, Inc. ("Dyne Therapeutics, Inc.") (NASDAQ:DYN) concerning possible violations of federal securities laws. Dyne issued a press release on September 3, 2024, "announc[ing] new clinical data from its ongoing Phase 1/2 DELIVER trial of DYNE-251 in patients with Duchenne muscular dystrophy (DMD) who are amenable to exon 51 skipping demonstrating unprecedented dystrophin expression and functional improvement in multiple cohorts.
2024-09-08 11:07:00
NEW YORK, NY / ACCESSWIRE / September 8, 2024 / If you suffered a loss on your American Airlines Group Inc. (NASDAQ:AAL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/american-airlines-lawsuit-submission-form?prid=101043&wire=1 or contact Joseph E. Levi, Esq.
2024-09-08 11:07:00
NEW YORK, NY / ACCESSWIRE / September 8, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Transocean Ltd. ("Transocean Ltd.
2024-09-08 11:07:00
NEW YORK, NY / ACCESSWIRE / September 8, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Liquidia Corporation ("Liquidia Corporation") (NASDAQ:LQDA) concerning possible violations of federal securities laws. On August 19, 2024, Liquidia shares have dropped 35% following an announcement that the FDA has postponed final approval of Liquidia's Yutrepia drug treating adults with pulmonary diseases.
2024-09-08 11:07:00
NEW YORK, NY / ACCESSWIRE / September 8, 2024 / If you suffered a loss on your MacroGenics, Inc. (NASDAQ:MGNX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/macrogenics-inc-lawsuit-submission-form?prid=101037&wire=1 or contact Joseph E. Levi, Esq.
2024-09-08 11:07:00
NEW YORK, NY / ACCESSWIRE / September 8, 2024 / If you suffered a loss on your Vicor Corporation (NASDAQ:VICR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/vicor-corporation-lawsuit-submission-form?prid=101039&wire=1 or contact Joseph E. Levi, Esq.
Kessler Topaz Meltzer & Check, LLP Encourages DexCom, Inc. Investors with Losses to Contact the Firm
2024-09-08 11:01:00
RADNOR, PA / ACCESSWIRE / September 8, 2024 / The law firm of Kessler Topaz Meltzer & Check, LLP(www.ktmc.com) informs investors that a securities class action lawsuit has been filed against DexCom, Inc. ("DexCom") (NASDAQ:DXCM) on behalf of investors who purchased or otherwise acquired DexCom securities between January 8, 2024 to July 25, 2024, inclusive (the "Class Period") The lead plaintiff deadline is October 21, 2024. CONTACT KESSLER TOPAZ MELTZER & CHECK, LLP: If you suffered DexCom losses, you may CLICK HERE or go to: https://www.ktmc.com/new-cases/dexcom-inc?utm_source=PR&utm_medium=link&utm_campaign=dxcm&mktm=r Please CLICK HERE to view our video or copy and paste this link into your browser: https://youtu.be/gzkLvw7x_7Y You can also contact attorney Jonathan Naji, Esq.
CAE Deadline: CAE Investors Have Opportunity to Lead CAE Inc. Securities Fraud Lawsuit
2024-09-08 11:00:00
NEW YORK , Sept. 8, 2024 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of stock of CAE Inc. (NYSE: CAE) between February 11, 2022 and May 21, 2024, both dates inclusive (the "Class Period"), of the important September 16, 2024 lead plaintiff deadline.
2024-09-08 11:00:00
NEW YORK, NY / ACCESSWIRE / September 8, 2024 / If you suffered a loss on your Lululemon Athletica Inc. (NASDAQ:LULU) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/lululemon-athletica-inc-lawsuit-submission-form?prid=101046&wire=1 or contact Joseph E. Levi, Esq.
FMP Articles
Travel+Leisure Co. (NYSE:TNL) - A Promising Investment in the Leisure and Hospitality Sector
M&T Bank Corporation's Financial Efficiency Analysis
DocuSign Stock Gains 3% Following Better-Than-Expected Earnings
Broadcom Shares Slide Over 9% After Underwhelming Sales Guidance Despite AI Growth
JPMorgan Downgrades Super Micro Computer on Regulatory Concerns, Lowers Price Target
Articles
Market Movers For 1/5/2024
The Investor Consensus 52-Week High Watchlist for 12/28/2023
Pre-market Gainers Report for 12/29/2023
Five Day Gainers as of 12/29/2023
What's Behind the 197% Surge in Canaan Inc. (Nasdaq: CAN)?
Analysts Predict Sky-High Future: Rocket Lab (RKLB) Gets $10 Target
Sphere 3D Corp. (Nasdaq: ANY) Surges 468% in a Month: What's Behind the Meteoric Rise?
EyePoint Pharmaceuticals, Inc. (Nasdaq: EYPT) Surges 278% on Positive Phase 2 Trial Results for EYP-1901 in Wet AMD
What's The Driving Force Behind NextPlay Technologies, Inc.'s (Nasdaq: NXTP) Remarkable Surge
Marathon Digital Holdings, Inc. (Nasdaq: MARA) Boosts Bitcoin Mining Capacity with $179 Million Acquisition
FuelCell Energy, Inc. (Nasdaq: FCEL) Reports Fourth Quarter and Fiscal Year 2023 Results: Revenue Performance in Focus
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) Rockets 13% Pre-Market with Positive Phase 2 Trial Results for ADX‑629 in Atopic Dermatitis
Compugen Ltd. (Nasdaq: CGEN) Soars 163% Pre-Market on Landmark Immunotherapy Deal with Gilead
Infobird Co., Ltd (Nasdaq: IFBD) Surges Over 66% Pre-Market on New IT System Software Development Partnership
Top Market Performers: Unveiling the Success Stories of MLGO, ALT, and RIVN Today!
Five Therapeutics Companies on a Winning Streak
Sera Prognostics Soars Over 260% as PRIME Study Hits Milestone
3 Cybersecurity Stocks Soaring to New Heights
What's Next for These Two High-Flying Stocks: Affirm Holdings, Inc. (AFRM) and Shopify Inc. (SHOP)
Amazon and Microsoft: Titans Riding the 52-Week High Wave
Five Stocks Reaching New 52-Week Highs on November 20, 2023
3 Stocks Surging on November 20, 2023: MIRA Pharmaceuticals, Inc. (Nasdaq: MIRA), Fortress Biotech, Inc. (Nasdaq: FBIO), and Safety Shot, Inc. (Nasdaq: SHOT)
5 Stocks with Bullish Momentum: Recent Analyst Upgrades
See What Wall Street Thinks About These 3 (AI) Stocks: NVIDIA Corporation (NVDA), C3.ai, Inc. (AI), and KLA Corporation (KLAC)
Illuminating the Path Ahead: Sunrun Inc. (Nasdaq: RUN) Receives Strong Buy Recommendations
Workday, Inc. (Nasdaq: WDAY) Enhances Workplace Productivity with New Generative AI Capabilities
Reata Pharmaceuticals, Inc. (Nasdaq: RETA) Achieves New 52-Week High, Soars Over 689%
Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) Advances with Decibel Therapeutics Acquisition
Symbotic Inc. (Nasdaq: SYM) vs. SoundHound AI, Inc. (Nasdaq SOUN): Exploring AI Stock Opportunities
Hot Stocks Alert: Activision Blizzard, Inc. (Nasdaq: ATVI) and Microsoft Corporation (Nasdaq: MSFT) Clear Regulatory Hurdles - Best Gaming Stocks for 2024?
Why Analyst James Lee of Raymond James is Turning Bullish and Upgrading DoorDash Inc. (DASH) : The Grocery Store Delivery App
Analyst Mark Moerdler of Bernstein Expresses Bullish Outlook on Microsoft Corporation (MSFT), Citing AI's Potential to Drive Higher Profits
CrowdStrike Holdings, Inc. (Nasdaq: CRWD): Analyst Sets Bullish $200.00 Price Target
Lululemon Athletica Inc. (Nasdaq: LULU)'s Smart Play in the Cross-Body Bag Game: From TikTok Trend to Must-Have Accessory
Analyst Matt Bryson Sets $80.00 Price Target for Micron Technology, Inc. (Nasdaq: MU)
What's Behind Greenland Technologies Holding Corporation (Nasdaq: GTEC) Surge?
MSP Recovery, Inc. (Nasdaq: LIFW) - LifeWallet's Surge: What's Behind the Recent Momentum
T2 Biosystems, Inc. (NASDAQ: TTOO) Hails CDC's Commitment to Battle Sepsis in U.S. Hospitals
Datasea Inc. (NASDAQ: DTSS) Empowers Its Future with $2 Million Public Offering Success
ABVC BioPharma, Inc. Progress in ADHD Phase IIb Clinical Study
Terran Orbital Corporation Soars to New Heights with 10 Satellite Deployment
FDA Greenlights Orchestra BioMed Holdings Innovative Hypertension Treatment